"10.1371_journal.pone.0118454","plos one","2015-03-03T00:00:00Z","Aukje C Bos; Cedric van Holsbeke; Jan W de Backer; Mireille van Westreenen; Hettie M Janssens; Wim G Vos; Harm A W M Tiddens","Department of Pediatric Pulmonology, Erasmus Medical Centre-Sophia Childrens Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Centre, Rotterdam, the Netherlands; FluidDA nv, Kontich, Belgium; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, the Netherlands","Conceived and designed the experiments: AB CvH JdB HJ WV HT. Performed the experiments: AB CvH WV. Analyzed the data: AB CvH HJ WV HT. Contributed reagents/materials/analysis tools: CvH JdB WV HT. Wrote the paper: AB CvH JdB MvW HJ WV HT.","This was an investigator initiated study. FluidDA nv received an unconditional grant from Gilead Sciences Inc. Author Cedric van Holsbeke and Wim G. Vos are employed by FluidDA nv. J. de Backer and Wim G. Vos are shareholders of FluidDA NV, a company that commercializes some of the techniques used in this manuscript. FluidDA NV covered the salary costs of the PhD student (AB) for the length of this study. HJ reports grants from Philips Respironics, grants from Novartis, grants from Chiesi, other from Teva Pharma, other from Philips Respironics, and other from Gilead, outside the submitted work. HT reports grants from Gilead Sciences Inc, during the conduct of the study; other from Roche, other from Pharmaxis, other from Novartis, grants from CFF, and grants from Vertex, outside the submitted work. In addition, Dr. Tiddens has the following patent ActivAero licensed (Improved Method for Treatment of Patients with Cystic Fibrosis, Patent No: 10763129.3-2112). All financial aspects of the above mentioned activities are handled by the BV Kindergeneeskunde of the ErasmusMC Sophia Childrens Hospital. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","03","Aukje C Bos","ACB",7,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
